12/17
08:05 am
dgx
Quest Diagnostics Incorporated (NYSE: DGX) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $172.00 price target on the stock, up previously from $145.00.
Low
Report
Quest Diagnostics Incorporated (NYSE: DGX) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $172.00 price target on the stock, up previously from $145.00.
12/17
08:05 am
dgx
Quest Diagnostics Incorporated (NYSE: DGX) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $172.00 price target on the stock, up previously from $145.00.
Low
Report
Quest Diagnostics Incorporated (NYSE: DGX) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $172.00 price target on the stock, up previously from $145.00.
12/17
06:14 am
dgx
Rating for DGX
Low
Report
Rating for DGX
12/17
06:14 am
dgx
Rating for DGX
Low
Report
Rating for DGX
12/17
04:40 am
dgx
Quest Diagnostics upgraded to Overweight from Equal Weight at Morgan Stanley
Low
Report
Quest Diagnostics upgraded to Overweight from Equal Weight at Morgan Stanley
12/17
04:40 am
dgx
Quest Diagnostics upgraded to Overweight from Equal Weight at Morgan Stanley
Low
Report
Quest Diagnostics upgraded to Overweight from Equal Weight at Morgan Stanley
12/10
06:16 am
dgx
Rating for DGX
Low
Report
Rating for DGX
12/10
06:16 am
dgx
Rating for DGX
Low
Report
Rating for DGX
10/24
08:45 am
dgx
Rating for DGX
Low
Report
Rating for DGX
10/24
08:45 am
dgx
Rating for DGX
Low
Report
Rating for DGX
10/23
11:20 am
dgx
Rating for DGX
Low
Report
Rating for DGX
10/23
09:33 am
dgx
Rating for DGX
Low
Report
Rating for DGX
10/23
09:33 am
dgx
Rating for DGX
Low
Report
Rating for DGX
10/23
09:03 am
dgx
Rating for DGX
Low
Report
Rating for DGX
10/23
09:03 am
dgx
Rating for DGX
Low
Report
Rating for DGX
10/23
07:35 am
dgx
Quest Diagnostics Incorporated (NYSE: DGX) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $182.00 price target on the stock, up previously from $157.00.
Low
Report
Quest Diagnostics Incorporated (NYSE: DGX) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $182.00 price target on the stock, up previously from $157.00.
10/23
07:00 am
dgx
Rating for DGX
Low
Report
Rating for DGX
10/23
07:00 am
dgx
Rating for DGX
Low
Report
Rating for DGX